Are These Consumer Staples Too Cheap for Investors to Ignore?

 | Sep 21, 2023 03:50PM ET

  • Consumer Staples stocks are down compared to the broad market, but that may be about to change.
  • These stocks offer value and yield and have a solid outlook for sustained performance and payouts.
  • The most undervalued names in the group stand to offer the most significant returns over the next decade.
  • 5 stocks we like better than Altria Group.
  • Consumer Staples Stocks are down 6.5% from their July highs and more than 10% from the 2022 peaks and may move lower. The caveat is that the sector is trading near the bottom of a range, above critical support, and there are signs of bullish activity in the market. This suggests a buying opportunity, but which are the best to buy? The stocks on this list turned up on a screen using Marketbeat's Stock Screener and include the most undervalued, highest-yielding consumer staples names with double-digit upside potential.

    The takeaway is that these stocks may be too cheap to ignore. With the Fed nearing the peak of the rate-hiking cycle, the market-beating yields and outlook for distribution growth and capital appreciation provide an opportunity that will outpace the bond trade and the broad equity market over the next decade.

    h2 Altria - A Cash Flow Machine and Dividend King /h2

    Altria Group (NYSE:MO) isn't an easy stock for every investor to hold, but let's face it: the company makes money and returns capital to shareholders, and it is unlikely to go out of business soon. Regarding its investment status, the stock trades at less than half the broad market average, about 8.5X its earnings outlook, and pays more than 9% in yield, with shares down more than 20% from the 2022 highs.

    Takeaways from the last earnings report include a widening margin and better-than-expected earnings despite a downtick in volume. Guidance was reaffirmed for EPS to grow by low single digits in 2023; analysts expect the bottom line growth to accelerate to the mid-single digits next year. Altria pays about 75% of its earnings, which is high but offset by the EPS growth outlook. The question is if the company can shift to cannabis successfully. Efforts to date have met with losses, but that is due primarily to the state of federal legalization.